Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Return on Equity (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 5 years of Return on Equity data on record, last reported at 4.93% in Q4 2025.

  • For Q4 2025, Return on Equity fell 830.0% year-over-year to 4.93%; the TTM value through Dec 2025 reached 4.93%, down 830.0%, while the annual FY2025 figure was 2.55%, 1237.0% up from the prior year.
  • Return on Equity reached 4.93% in Q4 2025 per VRCA's latest filing, down from 1.4% in the prior quarter.
  • Across five years, Return on Equity topped out at 14.74% in Q2 2024 and bottomed at 7.59% in Q1 2024.
  • Average Return on Equity over 5 years is 0.47%, with a median of 0.54% recorded in 2022.
  • Peak YoY movement for Return on Equity: skyrocketed 1510bps in 2024, then tumbled -1214bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.96% in 2021, then surged by 43bps to 0.54% in 2022, then crashed by -298bps to 2.16% in 2023, then skyrocketed by 256bps to 3.37% in 2024, then plummeted by -247bps to 4.93% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 4.93% in Q4 2025, 1.4% in Q3 2025, and 2.6% in Q2 2025.